Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of BION BB Biotech AG | -1.5% in 12m

Compare BION with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare BB Biotech AG with its related Sector/Index XBI

Compare BB Biotech AG with its related Sector/Index XBI

Performance Duell BION vs XBI

TimeFrame BION XBI
1 Day -0.12% -1.52%
1 Week 1.46% 1.45%
1 Month 0.72% 10.08%
3 Months -11.6% -1.30%
6 Months 10.4% 24.09%
12 Months -1.47% 6.83%
YTD 1.87% 1.05%
Rel. Perf. 1m -0.79
Rel. Perf. 3m 0.20
Rel. Perf. 6m -1.53
Rel. Perf. 12m -1.25

Is BB Biotech AG a good stock to buy?

Neither. Based on ValueRay Fundamental Analyses, BB Biotech AG is currently (May 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.13 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BION as of May 2024 is 43.16. This means that BION is currently overvalued and has a potential downside of 3.5% (Sold with Premium).

Is BION a buy, sell or hold?

BB Biotech AG has no consensus analysts rating. ValueRay therefore judges the recommendation based on the last 12 Month Returns of -1.47%.

In compare to SPDR S&P Biotech, BION made -8.3% less over the last 12 months. Due to the underperformance, it is recommend to sell BION.
Values above 0%: BION is performing better - Values below 0%: BION is underperforming

Compare BION with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -0.18% -6.21% -7.00% -29.78%
US NASDAQ 100 QQQ -0.50% -8.23% -5.67% -36.62%
US Dow Jones Industrial 30 DIA 0.07% -4.74% -4.39% -23.38%
German DAX 40 DBXD 1.70% -4.43% -6.77% -15.85%
UK FTSE 100 ISFU -0.08% -8.83% -5.85% -16.12%
Shanghai Shenzhen CSI 300 CSI 300 0.31% -4.01% 8.27% 5.81%
Hongkong Hang Seng HSI -0.69% -22.14% 6.70% 3.94%
Japan Nikkei 225 EXX7 0.40% -0.16% -1.39% -12.20%
India NIFTY 50 INDA -0.96% -2.48% -7.19% -31.29%
Brasil Bovespa EWZ 1.55% -2.57% 14.15% -14.18%

BION BB Biotech AG vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.27% -3.23% -6.79% -37.25%
Consumer Discretionary XLY 0.99% -4.55% 3.60% -20.30%
Consumer Staples XLP 0.41% -4.34% -3.93% -7.50%
Energy XLE -0.01% 0.73% -3.57% -24.83%
Financial XLF -0.53% -4.51% -11.54% -34.13%
Health Care XLV -0.53% -4.58% -3.92% -14.72%
Industrial XLI 1.32% -3.31% -8.94% -29.18%
Materials XLB 1.06% -2.87% -5.43% -21.07%
Real Estate XLRE -0.78% -7.31% 1.59% -12.33%
Technology XLK -1.11% -9.30% -4.27% -37.07%
Utilities XLU -0.04% -9.84% -8.17% -14.66%
Aerospace & Defense XAR 0.39% -7.64% -3.86% -25.90%
Biotech XBI 0.01% -9.36% -13.70% -8.30%
Homebuilder XHB 0.88% -6.28% -19.87% -52.32%
Retail XRT 1.94% -5.97% -9.71% -30.97%

BION BB Biotech AG vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 0.36% 3.10% 3.93% -21.92%
Natural Gas UNG -8.88% -30.82% 30.67% 34.52%
Gold GLD -1.96% -0.47% -11.58% -23.26%
Silver SLV -10.13% -9.17% -23.64% -33.17%
Copper CPER -4.20% -10.28% -21.27% -37.49%

Returns of BION vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 0.31% -2.15% 7.51% 4.70%
iShares High Yield Corp. Bond HYG 0.94% -1.53% 3.94% -12.14%
Does BB Biotech AG outperform its market, is BION a Sector Leader?
No, over the last 12 months BB Biotech AG (BION) made -1.47%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months BION made -11.58%, while XBI made -1.30%.
Period BION XBI S&P 500
1 Month 0.72% 10.08% 6.93%
3 Months -11.58% -1.30% 6.91%
12 Months -1.47% 6.83% 28.31%